Please login to the form below
Forbion
This page shows the latest Forbion news and features for those working in and with pharma, biotech and healthcare.
VC raises new €270m fund for European biotechs
Life sciences venture capital company Forbion has raised 270m in funding for European biotechs, in a sign that investment cash is returning to the sector. ... Forbion IV is a step up from its last fund, which raised 183m in 2016 with 70% earmarked for
Latest news
-
Amakem raises €18m for glaucoma treatment
In connection with this financing round Christina Takke (Forbion Capital Partners), Emmanuelle Coutanceau (Crédit Agricole Private Equity) and Gaston Matthyssens (Vesalius BioCapital) will join Amakem's board. ... Meanwhile Geert-Jan Mulder (Forbion
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- FDA approves two cell-based gene therapies for sickle cell disease
- Pfizer’s Elrexfio granted EC approval for relapsed and refractory multiple myeloma
- New economic data reveals risk of disincentivising UK life sciences growth
- WHO countries hold seventh INB meeting to prevent global pandemics
- The start of a beautiful friendship
- The future of patient partnerships
No results were found
PMHub
Kardex
Kardex is a global industry partner for intralogistics solutions and a leading supplier of automated storage solutions and material handling...
Latest intelligence
- Virtual care – negotiating barriers to adoption offers glimpses of an exciting future
- Digital tools and innovative healthcare promise to address pressing healthcare issues if they can satisfy concerns over access, security and affordability...
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
